Professor Simon Barry

University Professorial Research Fellow (E)

School of Biomedicine

Faculty of Health and Medical Sciences

Professor Simon C Barry
I have developed a collaborative research program in the discipline of Paediatrics which has both a basic science and a translational component. This allows me to undertake gene discovery and functional validation in vitro and then access human clinical material to determine whether there is a causal link with disease. I run a grant funded research group within the Robinson Research Institute, and. I currently have a group of 5 staff and 3 students working on three projects.

My Research
Career
Publications
Grants and Funding
Teaching
Supervision
Professional Activities
Contact

I have developed a collaborative research program in the discipline of Paediatrics which has both a basic science and a translational component. This allows me to undertake gene discovery and functional validation in vitro and then access human clinical material to determine whether there is a causal link with disease. I run a grant funded research group within the Robinson Research Institute, and. I currently have a group of 5 staff and 3 students working on three projects.

Basic research

My background in molecular biology and gene discovery while working at Immunex in Seattle lead me to use unbiased genome wide discovery platforms as a way to identify the key genes and pathways in a cell, and I have had a long standing interest in transcriptional regulation and how gene networks collaborate to shape a phenotype. I have applied this to the field of molecular immunology, and to the transcription factor FOXP3 in particular. FOXP3 is essential for the formation and function of regulatory T cells (Tregs), and without Treg, a fatal aggressive autoimmune disease occurs (known as IPEX in man, and SCURFY in mouse). Treg are the policemen of the immune system and are responsible for maintaining tolerance to health, and for maintaining immune homeostasis. The lack of Treg or Treg function is now accepted as part of the cause of many autoimmune diseases, including Type 1 diabetes, IBD, rheumatoid arthritis and multiple sclerosis, and hence Treg play a significant part in maintaining health. With consecutive funding from 3 NHMRC project grants, I have been able to use genome wide approaches to discover the key targets of FOXP3 in human Treg, and to validate their biological importance in vitro and in vivo. My group was the first in the world to achieve this for human FOXP3 and we discovered a key target of FOXP3, SATB1 which is regulated to maintain Treg function. This is an international collaboration, and is productivity is demonstrated by a new NHMRC grant in 2012 and a paper in Nature Immunology. I have also taken advantage of the new finding that FOXP3 may act as a tumour suppressor in human beast epithelia, and we have used our FOXP3 target discovery to uncover novel mechanisms by which FOXP3 may act as such a tumour suppressor. This project began as an honours project, grew to a Ph.D project, and received NHMRC project funding for 2012-15. We are also investigating the role of microRNAs in the regulation of the Treg gene network, and this has lead to a new collaboration on the role of miRs in reproduction and 2 NHMRC grants with Prof Sarah Robertson.

Translational Research

I also led a project team in the $68 million CRC for Biomarker Translation, which aims to discover novel Treg surface proteins with commercial partners BD and AMGEN. I bring novel surface protein candidates to this CRC from my NHMRC funded basic science project. The commercialisation process for these novel surface markers is underway, with two full US, Europe and Australia patents awarded to protect a novel cell surface biomarker of human regulatory T cells, and a cell therapy to treat diseases with a Treg defect. This project is now at the stage where we seek a commercial partner to undertake a pilot clinical trial and translate my research findings to commercial applications.

Most recently I was invited to join and lead a theme in a new CRC for cell therapy manufacturing, and this was awarded $53 million in Jan 2013. This CRC will further aid my commercialisation and translational research program by developing methods to generate a cell therapy at lower cost of goods. We have filed 2 patents from the work in this CRC, and have now launched a small Biotech start-up (Carina Biotech) to commercialise human T cell expansion technologies, and apply them for human clinical trials. This will make A Treg and CAR-T cell therapy feasible in the future, and will make it affordable for healthcare systems and for commercial applications

Appointments

Date	Position	Institution name
2017 - ongoing	Professor	Robinson Research Institute
2010 - ongoing	Chief Hospital Scientist	WCHN
2004 - 2017	Associate Professor	Robinson Research Insitute, University of Adelaide

Education

Date Institution name Country Title
1987 - 1991 National Institute for Medical Research United Kingdom Ph.D
1983 - 1987 King's College London United Kingdom B.Sc (hons)
Research Interests

Nutrition and Metabolic Health Child and Adolescent Health Immunology and Infection Innovative Therapeutics

Date	Institution name	Country	Title
1987 - 1991	National Institute for Medical Research	United Kingdom	Ph.D
1983 - 1987	King's College London	United Kingdom	B.Sc (hons)

Journals

Year	Citation
2023	Wong, Y. Y., Harbison, J. E., Hope, C. M., Gundsambuu, B., Brown, K. A., Wong, S. W., . . . Barry, S. C. (2023). Parallel recovery of chromatin accessibility and gene expression dynamics from frozen human regulatory T cells.. Scientific reports, 13(1), 5506. DOI
2023	Oakey, H., Giles, L. C., Thomson, R. L., Lê Cao, K. -A., Ashwood, P., Brown, J. D., . . . ENDIA Study Group. (2023). Protocol for a nested case-control study design for omics investigations in the Environmental Determinants of Islet Autoimmunity cohort. Annals of Medicine, 55(1), 1-14. DOI
2022	Tunbridge, M., Perkins, G. B., Singer, J., Salehi, T., Ying, T., Grubor-Bauk, B., . . . Coates, P. T. (2022). Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)-rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients.. Trials, 23(1), 780. DOI Scopus2 WoS1 Europe PMC1
2022	Elsemary, M. T., Maritz, M. F., Smith, L. E., Warkiani, M., Bandara, V., Napoli, S., . . . Thierry, B. (2022). Inertial microfluidic purification of CAR-T-Cell products. Advanced Biology, 6(1), 2101018-1-2101018-12. DOI Scopus2 WoS1
2022	Ryan, F. J., Hope, C. M., Masavuli, M. G., Lynn, M. A., Mekonnen, Z. A., Yeow, A. E. L., . . . Lynn, D. J. (2022). Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Medicine, 20(1), 26-1-26-23. DOI Scopus61 WoS58 Europe PMC58
2022	Bandala-Sanchez, E., Roth-Schulze, A. J., Oakey, H., Penno, M. A. S., Bediaga, N. G., Naselli, G., . . . ENDIA Study Group. (2022). Women with type 1 diabetes exhibit a progressive increase in gut Saccharomyces cerevisiae in pregnancy associated with evidence of gut inflammation.. Diabetes research and clinical practice, 184, 109189. DOI Scopus3 WoS2
2022	Hall, M., Oakey, H., Penno, M. A. S., McGorm, K., Anderson, A. J., Ashwood, P., . . . Cavenett, L. (2022). Mental Health During Late Pregnancy and Postpartum in Mothers With and Without Type 1 Diabetes: The ENDIA Study. Diabetes Care, 45(5), 1082-1090. DOI Scopus1 WoS1
2022	Perkins, G. B., Tunbridge, M., Salehi, T., Chai, C. S., Kireta, S., Johnston, J., . . . Coates, P. T. (2022). Concurrent vaccination of kidney transplant recipients and close household cohabitants against COVID-19. Kidney International, 101(5), 1077-1080. DOI Scopus5 WoS4 Europe PMC3
2022	Yan, J., Gundsambuu, B., Krasowska, M., Platts, K., Facal Marina, P., Gerber, C., . . . Blencowe, A. (2022). Injectable Diels-Alder cycloaddition hydrogels with tuneable gelation, stiffness and degradation for the sustained release of T-lymphocytes.. Journal of materials chemistry. B, 10(17), 3329-3343. DOI Scopus7 WoS6 Europe PMC3
2022	Garcia-Valtanen, P., Hope, C. M., Masavuli, M. G., Yeow, A. E. L., Balachandran, H., Mekonnen, Z. A., . . . Grubor-Bauk., B. (2022). SARS-CoV-2 Omicron variant escapes neutralising antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents.. Cell Reports Medicine, 3(6), 23 pages. DOI Scopus11 WoS9 Europe PMC11
2022	Liu, N., Sadlon, T., Wong, Y. Y., Pederson, S., Breen, J., & Barry, S. C. (2022). 3DFAACTS-SNP: using regulatory T cell-specific epigenomics data to uncover candidate mechanisms of type 1 diabetes (T1D) risk. Epigenetics and Chromatin, 15(1), 24-1-24-21. DOI
2021	Perveen, K., Quach, A., McPhee, A., Prescott, S. L., Barry, S. C., Hii, C. S., & Ferrante, A. (2021). Cord blood T cells expressing high and low PKCζ levels develop into cells with a propensity to display Th1 and Th9 cytokine profiles, respectively. International Journal of Molecular Sciences, 22(9), 1-16. DOI Scopus4 WoS4 Europe PMC3
2021	Harbison, J. E., Thomson, R. L., Wentworth, J. M., Louise, J., Roth‐Schulze, A., Battersby, R. J., . . . Couper, J. J. (2021). Associations between diet, the gut microbiome and short chain fatty acids in youth with islet autoimmunity and type 1 diabetes. Pediatric Diabetes, 22(3), 425-433. DOI Scopus2 WoS2 Europe PMC1
2021	Penno, M. A., Anderson, A. J., Thomson, R. L., McGorm, K., Barry, S. C., Colman, P. G., . . . ENDIA Study Group. (2021). Evaluation of protocol amendments to the Environmental Determinants of Islet Autoimmunity (ENDIA) study during the COVID-19 pandemic. Diabetic Medicine, 38(11), e14638-1-e14638-4. DOI Scopus1 WoS1 Europe PMC1
2021	Roth-Schulze, A. J., Penno, M. A. S., Ngui, K. M., Oakey, H., Bandala-Sanchez, E., Smith, A. D., . . . Harrison, L. C. (2021). Type 1 diabetes in pregnancy is associated with distinct changes in the composition and function of the gut microbiome. Microbiome, 9(1), 167-1-167-21. DOI Scopus19 WoS18 Europe PMC12
2021	Hope, C. M., Huynh, D., Wong, Y. Y., Oakey, H., Perkins, G. B., Nguyen, T., . . . Barry, S. C. (2021). Optimization of blood handling and peripheral blood mononuclear cell cryopreservation of low cell number samples. International Journal of Molecular Sciences, 22(17), 9129-1-9129-19. DOI Scopus3 WoS1
2021	Liu, N., Low, W. Y., Alinejad-Rokny, H., Pederson, S., Sadlon, T., Barry, S., & Breen, J. (2021). Seeing the forest through the trees: prioritising potentially functional interactions from Hi-C. Epigenetics & chromatin, 14(1), 1-17. DOI
2021	Ryan, F. J., Hope, C. M., Masavuli, M. G., Lynn, M. A., Mekonnen, Z. A., Lip Yeow, A. E., . . . Lynn, D. J. (2021). Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. DOI
2021	Garcia-Valtanen, P., Hope, C. M., Masavuli, M. G., Yeow, A. E. L., Balachandran, H., Mekonnen, Z. A., . . . Grubor-Bauk, B. (2021). COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infection. DOI
2021	Perveen, K., Quach, A., Stark, M. J., Prescott, S. L., Barry, S. C., Hii, C. S., & Ferrante, A. (2021). Characterization of the transient deficiency of PKC isozyme levels in immature cord blood T cells and its connection to anti-allergic cytokine profiles of the matured cells. International Journal of Molecular Sciences, 22(23), 12650-1-12650-16. DOI Scopus2 WoS2 Europe PMC2
2020	Macpherson, A. M., Barry, S. C., Ricciardelli, C., & Oehler, M. K. (2020). Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy.. J Clin Med, 9(9), 1-57. DOI Scopus9 WoS10 Europe PMC8
2020	Brown, C. Y., Sadlon, T., Hope, C. M., Wong, Y. Y., Wong, S., Liu, N., . . . Barry, S. C. (2020). Molecular Insights Into Regulatory T-Cell Adaptation to Self, Environment, and Host Tissues: Plasticity or Loss of Function in Autoimmune Disease. Frontiers in Immunology, 11(September), 1-17. DOI Scopus9 WoS7 Europe PMC8
2020	Liu, N., Sadlon, T., Wong, Y. Y., Pederson, S., Breen, J., & Barry, S. C. (2020). 3DFAACTS-SNP: Using regulatory T cell-specific epigenomics data to uncover candidate mechanisms of Type-1 Diabetes (T1D) risk. biorxiv. DOI
2020	Kim, J., Hope, C. M., Perkins, G. B., Stead, S. O., Scaffidi, J. C., Kette, F. D., . . . Coates, P. T. (2020). Rapamycin and abundant TCR stimulation are required for the generation of stable human induced regulatory T cells. Clinical & Translational Immunology, 9(12), 1-20. DOI Scopus2 WoS5 Europe PMC2
2020	Augustine, P., Gent, R., Louise, J., Taranto, M., Penno, M., Linke, R., . . . ENDIA Study Group. (2020). Pancreas size and exocrine function is decreased in young children with recent-onset Type 1 diabetes. Diabetic Medicine, 37(8), 1340-1343. DOI Scopus12 WoS8 Europe PMC9
2020	Schjenken, J. E., Moldenhauer, L. M., Zhang, B., Care, A. S., Groome, H. M., Chan, H. Y., . . . Robertson, S. A. (2020). MicroRNA miR-155 is required for expansion of regulatory T cells to mediate robust pregnancy tolerance in mice. Mucosal Immunology, 13(4), 609-625. DOI Scopus23 WoS24 Europe PMC15
2020	Brewer, K., Gundsambuu, B., Facal Marina, P., Barry, S. C., & Blencowe, A. (2020). Thermoresponsive Poly(ε-Caprolactone)-Poly(Ethylene/Propylene Glycol) Copolymers as Injectable Hydrogels for Cell Therapies.. Polymers, 12(2), 19 pages. DOI Scopus17 WoS17 Europe PMC4
2020	Kim, J., Hope, C. M., Gantumur, N., Perkins, G. B., Stead, S. O., Yue, Z., . . . Coates, P. T. (2020). Encapsulation of human natural and induced regulatory T-cells in IL-2 and CCL1 supplemented alginate-GelMA hydrogel for 3D bioprinting. Advanced Functional Materials, 30(15), 2000544-1-2000544-17. DOI Scopus23 WoS18
2020	Atashgaran, V., Dasari, P., Hodson, L. J., Evdokiou, A., Barry, S. C., & Ingman, W. V. (2020). Foxp3 heterozygosity does not overtly affect mammary gland development during puberty or the oestrous cycle in mice. Reproduction, Fertility and Development, 32(8), 774-782. DOI
2020	Penno, M. A., Oakey, H., Augustine, P., Taranto, M., Barry, S. C., Colman, P. G., . . . Couper, J. J. (2020). Changes in pancreatic exocrine function in young at-risk children followed to islet autoimmunity and type 1 diabetes in the ENDIA study. Pediatric Diabetes, 21(6), 945-949. DOI Scopus3 WoS2 Europe PMC2
2019	Hope, C. M., Welch, J., Mohandas, A., Pederson, S., Hill, D., Gundsambuu, B., . . . Barry, S. C. (2019). Peptidase inhibitor 16 identifies a human regulatory T-cell subset with reduced FOXP3 expression over the first year of recent onset type 1 diabetes. European Journal of Immunology, 49(8), 1235-1250. DOI Scopus8 WoS10 Europe PMC10
2019	Perveen, K., Quach, A., McPhee, A., Prescott, S. L., Barry, S. C., Hii, C. S., & Ferrante, A. (2019). Validation of monoclonal anti-PKC isozyme antibodies for flow cytometry analyses in human T cell subsets and expression in cord blood T cells. Scientific reports, 9(1), 9263-1-9263-11. DOI Scopus5 WoS5 Europe PMC5
2019	Moldenhauer, L. M., Schjenken, J. E., Hope, C. M., Green, E. S., Zhang, B., Eldi, P., . . . Robertson, S. A. (2019). Thymus-derived regulatory T cells exhibit Foxp3 epigenetic modification and phenotype attenuation after mating in mice. Journal of Immunology, 203(3), 647-657. DOI Scopus26 WoS24 Europe PMC10
2019	Wook Kim, K., Allen, D. W., Briese, T., Couper, J. J., Barry, S. C., Colman, P. G., . . . ENDIA Study Group. (2019). Distinct gut virome profile of pregnant women with type 1 diabetes in the ENDIA study. Open forum infectious diseases, 6(2), 1-8. DOI Scopus24 WoS21 Europe PMC17
2019	Robertson, S. A., Green, E. S., Care, A. S., Moldenhauer, L. M., Prins, J. R., Hull, M. L., . . . Dekker, G. (2019). Therapeutic potential of regulatory T cells in preeclampsia-opportunities and challenges. Frontiers in Immunology, 10(MAR), 478-1-478-18. DOI Scopus41 WoS36 Europe PMC24
2019	Schmidleithner, L., Thabet, Y., Schönfeld, E., Köhne, M., Sommer, D., Abdullah, Z., . . . Beyer, M. (2019). Enzymatic activity of HPGD in Treg cells Suppresses Tconv cells to maintain adipose tissue homeostasis and prevent metabolic dysfunction. Immunity, 50(5), 1232-1248.e14. DOI Scopus46 WoS44 Europe PMC32
2019	Harbison, J. E., Roth-Schulze, A. J., Giles, L. C., Tran, C. D., Ngui, K. M., Penno, M. A., . . . Couper, J. J. (2019). Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: a prospective cohort study. Pediatric Diabetes, 20(5), 574-583. DOI Scopus78 WoS70 Europe PMC56
2019	Kim, K. W., Allen, D. W., Briese, T., Couper, J. J., Barry, S. C., Colman, P. G., . . . ENDIA STUDY GROUP. (2019). Higher frequency of vertebrate-infecting viruses in the gut of infants born to mothers with type 1 diabetes. Pediatric Diabetes, 21(2), 271-279. DOI Scopus7 WoS5 Europe PMC6
2018	Penington, J. S., Penno, M., Ngui, K., Ajami, N., Roth-Schulze, A., Wilcox, S., . . . Giles, L. (2018). Influence of fecal collection conditions and 16S rRNA gene sequencing protocols at two centers on human gut microbiota analysis. Scientific Reports, 8, 10 pages. DOI
2018	Sadlon, T., Brown, C. Y., Bandara, V., Hope, C. M., Schjenken, J. E., Pederson, S. M., . . . Barry, S. C. (2018). Unravelling the molecular basis for regulatory T-cell plasticity and loss of function in disease. Clinical and Translational Immunology, 7(2), e1011-1-e1011-15. DOI Scopus19 WoS16 Europe PMC9
2018	Penington, J., Penno, M., Ngui, K., Ajami, N., Roth-Schulze, A., Wilcox, S., . . . Vuillermin, P. (2018). Influence of fecal collection conditions and 16S rRNA gene sequencing at two centers on human gut microbiota analysis. Scientific Reports, 8(1), 4386-1-4386-10. DOI Scopus29 WoS29 Europe PMC23
2018	Brown, C. Y., Dayan, S., Wong, S. W., Kaczmarek, A. K., Hope, C. M., Pederson, S. M., . . . Barry, S. C. (2018). FOXP3 and miR-155 cooperate to control the invasive potential of human breast cancer cells by down regulating ZEB2 independently of ZEB1. Oncotarget, 9(45), 27708-27727. DOI Scopus18 Europe PMC15
2017	Phillips, J., Couper, J., Penno, M., & Harrison, L. (2017). Type 1 diabetes: a disease of developmental origins. Pediatric Diabetes, 18(6), 417-421. DOI Scopus11 WoS11 Europe PMC5
2017	Robertson, S., Zhang, B., Chan, H., Sharkey, D., Barry, S., Fullston, T., & Schjenken, J. (2017). MicroRNA regulation of immune events at conception. Molecular Reproduction and Development, 84(9), 914-925. DOI Scopus17 WoS17 Europe PMC14
2017	Hinze, S., Jackson, M., Lie, S., Jolly, L., Field, M., Barry, S., . . . Shoubridge, C. (2017). Incorrect dosage of IQSEC2, a known intellectual disability and epilepsy gene, disrupts dendritic spine morphogenesis. Translational Psychiatry, 7(5), e1110-1-e-1110-11. DOI Scopus24 WoS25 Europe PMC15
2017	Worton, L., Shi, Y. -C., Smith, E., Barry, S., Gonda, T., Whitehead, J., & Gardiner, E. (2017). Ectodermal-neural cortex 1 isoforms have contrasting effects on MC3T3-E1 osteoblast mineralization and gene expression. Journal of Cellular Biochemistry, 118(8), 2141-2150. DOI Scopus4 WoS4 Europe PMC4
2017	Delalat, B., Harding, F., Gundsambuu, B., De-Juan-Pardo, E., Wunner, F., Wille, M., . . . Barry, S. (2017). 3D printed lattices as an activation and expansion platform for T cell therapy. Biomaterials, 140, 58-68. DOI Scopus25 WoS22 Europe PMC11
2017	Ivask, A., Mitchell, A., Hope, C., Barry, S., Lombi, E., & Voelcker, N. (2017). Single cell level quantification of nanoparticle-cell interactions using mass cytometry. Analytical Chemistry, 89(16), 8228-8232. DOI Scopus27 WoS22 Europe PMC4
2017	Maartens, J., De-Juan-Pardo, E., Wunner, F., Simula, A., Voelcker, N., Barry, S., & Hutmacher, D. (2017). Challenges and opportunities in the manufacture and expansion of cells for therapy. Expert Opinion on Biological Therapy, 17(10), 1221-1233. DOI Scopus10 WoS10 Europe PMC5
2016	Atashgaran, V., Wrin, J., Barry, S., Dasari, P., & Ingman, W. (2016). Dissecting the biology of menstrual cycle-associated breast cancer risk. Frontiers in Oncology, 6(DEC), 1-10. DOI Scopus30 WoS28 Europe PMC19
2016	Thomas, C., Forrest, A., Klingberg, H., Moore, D., Abu-Assi, R., Barry, S., & Khurana, S. (2016). Does Gastrostomy Placement With Concurrent Fundoplication Increase the Risk of Gastrostomy-related Complications?. Journal of Pediatric Gastroenterology and Nutrition, 63(1), 29-33. DOI Scopus4 WoS6 Europe PMC4
2015	Jolly, L., Nguyen, L., Domingo, D., Sun, Y., Barry, S., Hancarova, M., . . . Gecz, J. (2015). HCFC1 loss-of-function mutations disrupt neuronal and neural progenitor cells of the developing brain.. Human Molecular Genetics, 24(12), 3335-3347. DOI Scopus30 WoS28 Europe PMC28
2015	Prins, J., Zhang, B., Schjenken, J., Guerin, L., Barry, S., & Robertson, S. (2015). Unstable Foxp3p⁺ regulatory T cells and altered dendritic cells are associated with lipopolysaccharide-induced fetal loss in pregnant interleukin 10-deficient mice. Biology of Reproduction, 93(4), 95-1-95-14. DOI Scopus27 WoS25 Europe PMC14
2013	Jolly, L., Homan, C., Jacob, R., Barry, S., & Gecz, J. (2013). The UPF3B gene, implicated in intellectual disability, autism, ADHD and childhood onset schizophrenia regulates neural progenitor cell behaviour and neuronal outgrowth. Human Molecular Genetics, 22(23), 4673-4687. DOI Scopus79 WoS75 Europe PMC63
2013	Penno, M., Couper, J., Craig, M., Colman, P., Rawlinson, W., Cotterill, A., . . . Wentworth, J. (2013). Environmental determinants of islet autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of type 1 diabetes. BMC Pediatrics, 13(1), 1-15. DOI Scopus45 WoS39 Europe PMC22
2012	Grose, R., Millard, D., Mavrangelos, C., Barry, S., Zola, H., Nicholson, I., . . . Krumbiegel, D. (2012). Comparison of blood and synovial fluid Th17 and novel peptidase inhibitor 16 Treg cell subsets in juvenile idiopathic arthritis. Journal of Rheumatology, 39(10), 2021-2031. DOI Scopus7 WoS6 Europe PMC6
2012	Hill, D., Eastaff-Leung, N., Bresatz-Atkins, S., Warner, N., Ruitenberg, J., Krumbiegel, D., . . . Barry, S. (2012). Inhibition of activation induced CD154 on CD4⁺ CD25⁻ cells: a valid surrogate for human Treg suppressor function. Immunology and Cell Biology, 90(8), 812-821. DOI Scopus12 WoS10 Europe PMC9
2012	Nicholson, I., Mavrangelos, C., Bird, D., Bresatz-Atkins, S., Eastaff-Leung, N., Grose, R., . . . Krumbiegel, D. (2012). PI16 is expressed by a subset of human memory Treg with enhanced migration to CCL17 and CCL20. Cellular Immunology, 275(1), 12-18. DOI Scopus18 WoS19 Europe PMC14
2012	McInnes, N., Sadlon, T., Brown, C., Pederson, S., Beyer, M., Schultze, J., . . . Barry, S. (2012). FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells. Oncogene, 31(8), 1045-1054. DOI Scopus89 WoS82 Europe PMC67
2011	Skalamera, D., Ranall, M., Wilson, B., Leo, P., Purdon, A., Hyde, C., . . . Gonda, T. (2011). A high-throughput platform for lentiviral overexpression screening of the human ORFeome. PLoS One, 6(5), e20057-1-e20057-14. DOI Scopus37 WoS38 Europe PMC28
2011	Beyer, M., Sadlon, T., & Barry, S. (2011). Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation. Nature Immunology, 12(9), 898-907. DOI Scopus156 WoS152 Europe PMC114
2011	Roberts-Thomson, I., Fon, J., Uylaki, W., Cummins, A., & Barry, S. (2011). Cells, cytokines and inflammatory bowel disease: A clinical perspective. Expert Review of Gastroenterology and Hepatology, 5(6), 703-716. DOI Scopus96 WoS86 Europe PMC62
2010	Eastaff-Leung, N., Mabarrack, N., Barbour, A., Cummins, A., & Barry, S. (2010). Foxp3⁺ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. Journal of Clinical Immunology, 30(1 Sp Iss), 80-89. DOI Scopus310 WoS291 Europe PMC228
2010	Brown, C., Sadlon, T., Gargett, T., Melville, E., Zhang, R., Drabsch, Y., . . . Barry, S. (2010). Robust, reversible gene knockdown using a single lentiviral short hairpin RNA vector. Human Gene Therapy, 21(8), 1005-1017. DOI Scopus26 WoS27 Europe PMC22
2010	Sadlon, T., Wilkinson, B., Pederson, S., Brown, C., Bresatz, S., Gargett, T., . . . Barry, S. (2010). Genome-wide identification of human FOXP3 target genes in natural regulatory T cells. Journal of Immunology, 185(2), 1071-1081. DOI Scopus106 WoS105 Europe PMC80
2009	Li, S., Floess, S., Hamann, A., Gaudieri, S., Lucas, A., Hellard, M., . . . Gowans, E. (2009). Analysis of FOXP3+ regulatory T cells that display apparent viral antigen specificity during chronic hepatitis C virus infection. PLoS Pathogens, 5(12), 1000707-1-1000707-13. DOI Scopus30 WoS44 Europe PMC26
2009	Hutton, J., Gargett, T., Sadlon, T., Bresatz, S., Brown, C., Zola, H., . . . Barry, S. (2009). Development of CD4⁺CD25⁺FoxP3⁺ regulatory T cells from cord blood hematopoietic progenitor cells. Journal of Leukocyte Biology, 85(3), 445-451. DOI Scopus28 WoS19 Europe PMC19
2008	Gregory, P., Bert, A., Paterson, E., Barry, S., Tsykin, A., Farshid, G., . . . Goodall, G. (2008). The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nature Cell Biology, 10(5), 593-601. DOI Scopus3190 WoS3013 Europe PMC2485
2008	Drabsch, Y., Hugo, H., Zhang, R., Dowhan, D. H., Miao, Y. R., Gewirtz, A. M., . . . Gonda, T. J. (2008). Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells (Proceedings of the National Academy of Sciences of the United States of America (2007) 104, (13762-13767) DOI: 10.1073/pnas.0700104104). Proceedings of the National Academy of Sciences of the United States of America, 105(2), 825. DOI Scopus1 WoS1
2007	Brzezinski, M., Yanay, O., Waldron, L., Barry, S., & Osborne, W. (2007). G-CSF-lentivirus administration in rats provided sustained elevated neutrophil counts and subsequent EPO-lentivirus administration increased hematocrits. Journal of Gene Medicine, 9(7), 571-578. DOI Scopus4 WoS4 Europe PMC4
2007	Bresatz, S., Sadlon, T., Millard, D., Zola, H., & Barry, S. (2007). Isolation, propagation and characterization of cord blood derived CD4+ CD25+ regulatory T cells. Journal of Immunological Methods, 327(1-2), 53-62. DOI Scopus23 WoS21 Europe PMC19
2007	Drabsch, Y., Hugo, H., Zhang, R., Dowhan, D., Miao, Y., Gewirtz, A., . . . Gonda, T. (2007). Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America, 104(34), 13762-13767. DOI Scopus102 WoS106 Europe PMC88
2007	Zola, H., Swart, B., Banham, A., Barry, S., Beare, A., Bensussan, A., . . . Yang, X. (2007). CD molecules 2006 - Human cell differentiation molecules. Journal of Immunological Methods, 319(1-2), 1-5. DOI Scopus103 WoS78 Europe PMC56
2007	Barry, S., & Coates, P. (2007). Retroviral escape by Friendly infected DCs [Comment on Balkow et al, page 3949]. Blood, 110(12), 3819-3820. DOI
2005	Barry, S., Brzezinski, M., Yanay, O., Seppen, J., & Osborne, W. (2005). Sustained elevation of neutrophils in rats induced by lentivirus-mediated G-CSF delivery. Journal of Gene Medicine, 7(12), 1510-1516. DOI Scopus3 WoS3 Europe PMC3
2003	Yanay, O., Barry, S., Katen, L., Brzezinski, M., Flint, L., Christensen, J., . . . Osborne, W. (2003). Treatment of canine cyclic neutropenia by lentivirus-mediated G-CSF delivery. Blood, 102(6), 2046-2052. DOI Scopus16 WoS13 Europe PMC10
2003	Yanay, O., Barry, S., Flint, L., Brzezinski, M., Barton, R., & Osborne, W. (2003). Long-Term erythropoietin gene expression from transduced cells in bioisolator devices. Human Gene Therapy, 14(17), 1587-1593. DOI Scopus19 WoS18 Europe PMC14
2001	Barry, S., Harder, B., Brezezinski, M., Flint, L., Seppen, J., & Osborne, W. (2001). Lentivirus vectors encoding both central polypurine tract and posttranscriptional regulatory element provide enhanced transduction and transgene expression. Human Gene Therapy, 12(9), 1103-1108. DOI Scopus114 WoS114 Europe PMC100
2001	Barry, S., Ramesh, N., Lejnieks, D., Simonson, W., Kemper, L., Lernmark, A., & Osborne, W. (2001). Glucose-regulated insulin expression in diabetic rats. Human Gene Therapy, 12(2), 131-140. DOI Scopus23 WoS22 Europe PMC16
2001	Seppen, J., Barry, S., Harder, B., & Osborne, W. (2001). Lentivirus administration to rat muscle provides efficient sustained expression of erythropoietin. Blood, 98(3), 594-596. DOI Scopus50 WoS43 Europe PMC37
2001	Jones, K., Bagley, C., Butcher, C., Barry, S., Vadas, M., & D'Andrea, R. (2001). Peptide insertions in domain 4 of hbc, the shared signalling receptor subunit for GM-CSF, IL3 and IL5, induce ligand-independent activation. Cytokine, 14(6), 303-315. DOI Scopus2 WoS2
2000	Barry, S. C., Seppen, J., Ramesh, N., Foster, J. L., Seyama, K., Ochs, H. D., . . . Osborne, W. R. A. (2000). Lentiviral and murine retroviral transduction of T cells for expression of human CD40 ligand. Human Gene Therapy, 11(2), 323-332. DOI Scopus23 WoS21 Europe PMC13
2000	Seppen, J., Barry, S. C., Klinkspoor, J. H., Katen, L. J., Lee, S. P., Garcia, J. V., & Osborne, W. R. A. (2000). Apical gene transfer into quiescent human and canine polarized intestinal epithelial cells by lentivirus vectors. Journal of Virology, 74(16), 7642-7645. DOI Scopus37 WoS35 Europe PMC31
2000	Seppen, J., Barry, S., Lam, G. M., Ramesh, N., & Osborne, W. R. A. (2000). Retroviral preparations derived from PA317 packaging cells contain inhibitors that copurify with viral particles and are devoid of viral vector RNA. Human Gene Therapy, 11(5), 771-775. DOI Scopus14 WoS14 Europe PMC12
1997	Barry, S., Korpelainen, E., Sun, Q., Stomski, F., Moretti, P., Wakao, H., . . . Goodall, G. (1997). Roles of the N and C terminal domains of the interleukin-3 receptor alpha chain in receptor function.. Blood, 89(3), 842-852. DOI Scopus51 WoS53 Europe PMC26
1996	Coulter, C., Read, L., Carr, B., Tarantal, A., Barry, S., & Styne, D. (1996). A role for EGF in the morphological and functional maturation of the adrenal gland in the fetal rhesus monkey in vivo. Journal of Clinical Endocrinology and Metabolism, 81(3), 1254-1260.
1996	D'Andrea, R. J., Barry, S. C., Moretti, P. A. B., Jones, K., Ellis, S., Vadas, M. A., & Goodall, G. J. (1996). Extracellular truncations of hβc, the common signaling subunit for interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF), and IL-5, lead to ligand-independent activation. Blood, 87(7), 2641-2648. DOI Scopus25 WoS25 Europe PMC11
1994	Barry, S. C., Bagley, C. J., Phillips, J., Dottore, M., Cambareri, B., Moretti, P., . . . Lopez, A. F. (1994). Two contiguous residues in human interleukin-3, Asp<sup>21</sup> and Glu<sup>22</sup>, selectively interact with the α- and β-chains of its receptor and participate in function. Journal of Biological Chemistry, 269(11), 8488-8492. DOI Scopus69 WoS75 Europe PMC34
1992	Lopez, A. F., Shannon, M. F., Barry, S., Phillips, J. A., Cambareri, B., Dottore, M., . . . Vadas, M. A. (1992). A human interleukin 3 analog with increased biological and binding activities. Proceedings of the National Academy of Sciences of the United States of America, 89(24), 11842-11846. DOI Scopus37 WoS41 Europe PMC20
1991	McKenzie, A. N. J., Barry, S. C., Strath, M., & Sanderson, C. J. (1991). Structure-function analysis of interleukin-5 utilizing mouse/human chimeric molecules. EMBO Journal, 10(5), 1193-1199. DOI Scopus55 WoS61 Europe PMC37
1991	Barry, S. C., McKenzie, A. N. J., Strath, M., & Sanderson, C. J. (1991). Analysis of interleukin 5 receptors on murine eosinophils: A comparison with receptors on B13 cells. Cytokine, 3(4), 339-344. DOI Scopus7 WoS8 Europe PMC1
-	Garcia Valtanen, P., Hope, C. M., Masavuli, M. G., Yeow, A., Balachandran, H., Mekonnen, Z. A., . . . Grubor-Bauk, B. (n.d.). 'One Year Later' - SARS-CoV-2-Specific Immunity in Mild Cases of COVID-19.

Conference Papers

Year	Citation
2022	Tunbridge, M. J., Perkins, G., Salehi, T., Grubor-Bauk, B., Sim, B., Ying, T., . . . Coates, P. T. (2022). A Prospective Randomised, Controlled Trial Switching Sirolimus for Mycophenolate to Enhance Immunological Responses to Third Dose COVID-19 Vaccination in Kidney Transplant Recipients with Poor Baseline Humoral Immunity. In AMERICAN JOURNAL OF TRANSPLANTATION Vol. 22 (pp. 1095). ELECTR NETWORK: WILEY.
2022	Perkins, G. B., Tunbridge, M., Salehi, T., Chai, C., Hope, C. M., Garcia-Valtanen, P., . . . Coates, P. (2022). Sirolimus Use is Associated with an Improved Immune Response to COVID-19 Vaccination in Kidney Transplant Recipients. In AMERICAN JOURNAL OF TRANSPLANTATION Vol. 22 (pp. 873). WILEY.
2018	Bird, T. G., Mueller, M., Boulter, L., Vincent, D., Ridgway, R., Lopez Guadamillas, E., . . . Forbes, S. J. (2018). Inhibiting Senescence Induced By Macrophage Derived Tgf beta Restores a Regenerative Response and Improves Survival Following Acetaminophen Poisoning. In HEPATOLOGY Vol. 68 (pp. 200A-201A). San Francisco, CA: WILEY.
2018	Robertson, S. A., Zhang, B., Barry, S. C., Schjenken, J. E., & Moldenhauer, L. M. (2018). miRNA-155 is required to induce competent regulatory T cells and to protect against inflammation-induced fetal loss in mice. In CLINICAL ENDOCRINOLOGY Vol. 89 (pp. 36-37). Perth, AUSTRALIA: WILEY.
2018	Kim, J., Yue, Z., Liu, X., Hope, C., Rojas-Canales, D., Drogemuller, C., . . . Coates, P. T. (2018). Characterization of 3D-Printed Human Regulatory T-Cells. In TRANSPLANTATION Vol. 102 (pp. S109). Madrid, SPAIN: LIPPINCOTT WILLIAMS & WILKINS. DOI
2016	Mohandas, A., Hill, D., Hope, C., Pederson, S., Walsh, J., Grose, R., . . . Barry, S. C. (2016). A new biomarker of stable regulatory T cell function which has diagnostic utility in type 1 diabetes. In EUROPEAN JOURNAL OF IMMUNOLOGY Vol. 46 (pp. 748). Melbourne, AUSTRALIA: WILEY-BLACKWELL.
2016	Malatesta, K., Sadlon, T., Pederson, S., Brown, C., & Barry, S. C. (2016). Validating the contribution of microRNAs and lncRNAs to the molecular signature and plasticity of iTreg vs. nTreg in humans. In EUROPEAN JOURNAL OF IMMUNOLOGY Vol. 46 (pp. 1216). Melbourne, AUSTRALIA: WILEY-BLACKWELL.
2016	Brown, C., Beyer, M., Pederson, S., Goodall, G., Schultze, J., Sadlon, T., & Barry, S. C. (2016). FOXP3 tightly controls target gene expression using microRNAs in human regulatory T cells, and regulates Treg plasticity. In EUROPEAN JOURNAL OF IMMUNOLOGY Vol. 46 (pp. 1216). Melbourne, AUSTRALIA: WILEY-BLACKWELL.
2016	Harding, F., Delalat, B., Guundsambuu, B., Pardo, E., Hutmacher, D., Voelcker, N., & Barry, S. C. (2016). A novel human T cell expansion technology for affordable cell therapy. In EUROPEAN JOURNAL OF IMMUNOLOGY Vol. 46 (pp. 747). Melbourne, AUSTRALIA: WILEY-BLACKWELL.
2015	Muhling, J., Russell, D., & Barry, S. (2015). USE OF VIRAL VECTORS IN PRIMARY CELLS. In JOURNAL OF GENE MEDICINE Vol. 17 (pp. 214-215). Univ Melbourne, Univ Coll, Parkville, AUSTRALIA: WILEY-BLACKWELL.
2014	Mohandas, A., Zola, H., Barry, S., & Krumbiegel, D. (2014). Peptidase inhibitor 16 identifies a unique subset of memory T helper cells with hyperproliferative and proinflammatory properties. In JOURNAL OF IMMUNOLOGY Vol. 192 (pp. 1 page). AMER ASSOC IMMUNOLOGISTS.

Conference Items

Year	Citation
2020	Kim, J., Hope, C. M., Scaffidi, J. C., Stead, S. O., Perkins, G. B., Kette, F. D., . . . Coates, P. T. (2020). GENERATION OF STABLE HUMAN INDUCED REGULATORY T-CELLS REQUIRES OPTIMAL RAPAMYCIN CONCENTRATION AND TCR STIMULATION. Poster session presented at the meeting of TRANSPLANTATION. ELECTR NETWORK: LIPPINCOTT WILLIAMS & WILKINS.
2018	Lowe, K., Huan, D., Rebuli, M., Golley, S., Tran, C., & Barry, S. C. (2018). Is the dual sugar test of intestinal permeability diagnostic for determining altered barrier function?. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY.
2014	Prins, J. R., Guerin, L. R., Zhang, B., Schjenken, J. E., Barry, S. C., & Robertson, S. A. (2014). Interleukin-10 deficiency causes dysregulation of the regulatory T cell response to pregnancy in mice. Poster session presented at the meeting of Reproductive Sciences. Florence, Italy: SAGE Publications. DOI
2013	Bresatz, S., Ang, G., Eastaff-Leung, N., Hill, D., Pederson, S., Grose, R., . . . Barry, S. C. (2013). Novel FOXP3 surrogate biomarkers on human Treg. Poster session presented at the meeting of Journal of Gastroenterology and Hepatology. Melbourne, Vic.: Wiley. DOI

Patents

Year Citation
2014 Barry, S. (2014). 2408934, Peptidase Inhibitor 16(PI16) as a Biomarker for Regulatory T (TREG) Cells and Uses Thereof. Europe.
Theses

Year Citation
2018 Pederson, S. M. (2018). BMEA: Bayesian Modelling for Exon Array Data. (PhD Thesis, University of Adelaide).

Year	Citation
2014	Barry, S. (2014). 2408934, Peptidase Inhibitor 16(PI16) as a Biomarker for Regulatory T (TREG) Cells and Uses Thereof. Europe.

Year	Citation
2018	Pederson, S. M. (2018). BMEA: Bayesian Modelling for Exon Array Data. (PhD Thesis, University of Adelaide).

Summary of major funding

Since my arrival in Jan 2004, I have been successful in attracting over $3.2 million in research funding ($1,210,500 currently to my lab), including 5 NHMRC project grants as CIA, an NHMRC program grant as CID and an ARC linkage grant as CIA. As a co senior applicant I am a CI on 2 NHMRC project grants, and 2 Cooperative Research Centre programs. In collaboration with a national team lead by Prof Couper I am a named chief investigator on the ENDIA study, a $10 million birth cohort study funded by the JDRF and Helmsley trust. In addition, I have attracted a number of small grants as CIA and a commercial partnership. I am named CI on 4 NHMRC project applications under consideration in the current round. From 2006, my successful grant application rate is over 80%. This has allowed growth in staff in my group, and allowed a number of collaborations to be initiated, and these are now yielding high impact publications.

Barry Group Funding

Teaching

Annual lecture delivery to year 3 Infection and Immunity course in the Bachelor of Science degree (Faculty of Science, School of Biological Sciences, Department of Molecular and Cellular Biology. This course is coordinated by Prof Shaun McColl, and is managed by Chris Wong and Jamie Botten. I have been delivering a research and training lecture to this course since 2006, and although I have not received SELT scores for my contribution to this, I have been invited to teach in this course for 8 years, and I have doubled the number of lectures I deliver since 2014.

Current Higher Degree by Research Supervision (University of Adelaide)

Date	Role	Research Topic	Program	Degree Type	Student Load	Student Name
2023	Principal Supervisor	Investigating the role of JAZF1 in the formation and function of human induced Regulatory T cells	Doctor of Philosophy	Doctorate	Full Time	Miss Hannah Rae Morgan
2023	Principal Supervisor	Investigating regulatory T cells post COVID-19	Doctor of Philosophy	Doctorate	Full Time	Ms Sarah May Battersby
2022	Principal Supervisor	Functional validation of enhancers linked with Type 1 Diabetes using CRISPR Cas9 tools.	Doctor of Philosophy	Doctorate	Full Time	Miss Leela Amy Balin
2022	Principal Supervisor	Optimisation of Chimeric Antigen Receptor T Cells for Pan Solid Tumour Immunotherapy	Doctor of Philosophy	Doctorate	Full Time	Mr Jieren Zheng
2021	Co-Supervisor	Investigating the role of JAZF1 in human regulatory T cells	Doctor of Philosophy	Doctorate	Full Time	Miss Kate Louise Shepherdson
2021	Co-Supervisor	The Development of Chimeric Antigen Receptor Regulatory T cells (CAR-Tregs) as a Novel Therapy for Autoimmune-driven Type 1 Diabetes (T1D)	Doctor of Philosophy	Doctorate	Full Time	Ms Jacqueline Claire Scaffidi
2020	Principal Supervisor	Is the loss of immunological tolerance in children with Type 1 Diabetes caused by altered transcription in their T cells?	Doctor of Philosophy	Doctorate	Full Time	Miss Holly Amber Withers
2020	Co-Supervisor	Development of novel ovarian cancer treatment using CAR-T cells targeting LGR5	Doctor of Philosophy	Doctorate	Full Time	Miss Wanqi Wang
2019	Principal Supervisor	Does the SATBI superenhancer prevent autoimmunity in mice?	Doctor of Philosophy	Doctorate	Full Time	Miss Katherine Alexandra Brown
2016	Co-Supervisor	Physiological Immunodeficiency of Immaturity of the Neonate- a Window of Opportunity for Attaining a Healthy Development	Doctor of Philosophy	Doctorate	Full Time	Mrs Khalida Perveen

Past Higher Degree by Research Supervision (University of Adelaide)

Date	Role	Research Topic	Program	Degree Type	Student Load	Student Name
2018 - 2020	Co-Supervisor	Three-Dimensional Printing of Regulatory T-Cells: A Novel Immunotherapy to Prevent Transplantation Rejection	Doctor of Philosophy	Doctorate	Full Time	Mr Juewan Kim
2017 - 2021	Co-Supervisor	Three-dimensional regulation: Establishing novel linkages between non-coding genetic variation and target genes	Doctor of Philosophy	Doctorate	Full Time	Mr Ning Liu
2017 - 2021	Principal Supervisor	The Identification Of Genetic And Epigenetic Changes That Contribute To Type 1 Diabetes	Doctor of Philosophy	Doctorate	Full Time	Dr Ying Ying Wong
2016 - 2021	Principal Supervisor	A NOVEL ROLE FOR ZEB2 AS A LINEAGE FIDELITY CHECKPOINT IN HUMAN CD4+ T CELLS	Doctor of Philosophy	Doctorate	Full Time	Mr Soon Wei Wong
2015 - 2018	Co-Supervisor	Hormone and transcription factor regulation of cytokines in the mammary gland	Doctor of Philosophy	Doctorate	Full Time	Mr Vahid Atashgaran
2013 - 2021	Co-Supervisor	DOES THE GUT MICROBIOME DRIVE THE DEVELOPMENT OF TYPE 1 DIABETES? Type 1 diabetes and the gut (TIGs) cohort	Doctor of Philosophy	Doctorate	Part Time	Dr Jessica Emily Harbison
2013 - 2018	Co-Supervisor	T Regulatory Cells in Early Pregnancy in Mice	Doctor of Philosophy	Doctorate	Full Time	Miss Bihong Zhang
2011 - 2013	Co-Supervisor	Longevity of Airway Gene Therapy for Cystic Fibrosis: Single and Repeat Lentiviral Dosing	Doctor of Philosophy	Doctorate	Part Time	Dr Patricia Lucia Cmielewski
2011 - 2015	Co-Supervisor	Characterisation of PI16+ T helper cells	Doctor of Philosophy	Doctorate	Full Time	Mr Arunesh Pullaniparambil Mohandas
2011 - 2015	Co-Supervisor	Cystic Fibrosis: The role of airway stem cells in sustained gene expression by lentiviral directed gene therapy	Doctor of Philosophy	Doctorate	Full Time	Dr Nigel Farrow
2009 - 2013	Principal Supervisor	A Tumour Suppressor Role for FOXP3 and FOXP3-regulated MicroRNAs in Breast Cancer Cells	Doctor of Philosophy	Doctorate	Full Time	Miss Natasha McInnes
2008 - 2018	Principal Supervisor	BMEA: Bayesian Modelling for Exon Array Data	Doctor of Philosophy	Doctorate	Part Time	Dr Stephen Martin Pederson
2006 - 2009	Co-Supervisor	Regulatory T Cells, Th17 Effector Cells and Cytokine Microenvironment in Inflammatory Bowel Disease and Coeliac Disease	Doctor of Philosophy	Doctorate	Part Time	Dr Nicola Eastaff-Leung

Board Memberships

Date Role Board name Institution name Country
2015 - ongoing Board Member Cell bank Australia children's medical research institute Australia
Committee Memberships

Date Role Committee Institution Country
2014 - ongoing Member RRI Executive Robinson Research Institute Australia
2009 - ongoing Vice-Chair WCHN IBC WCHN Australia
Memberships

Date Role Membership Country
2014 - ongoing Member ISCT Australia
2004 - ongoing Member ASI Australia
Editorial Boards

Date Role Editorial Board Name Institution Country
2016 - ongoing Associate Editor Frontiers in Immunology Robinson Research Insitute Australia
Industry Partnerships

Date Engagement Type Partner Name
2011 - ongoing Consultant BeckTon Dickenson

Date	Role	Board name	Institution name	Country
2015 - ongoing	Board Member	Cell bank Australia	children's medical research institute	Australia

Date	Role	Committee	Institution	Country
2014 - ongoing	Member	RRI Executive	Robinson Research Institute	Australia
2009 - ongoing	Vice-Chair	WCHN IBC	WCHN	Australia

Date	Role	Membership	Country
2014 - ongoing	Member	ISCT	Australia
2004 - ongoing	Member	ASI	Australia

Date	Role	Editorial Board Name	Institution	Country
2016 - ongoing	Associate Editor	Frontiers in Immunology	Robinson Research Insitute	Australia

Date	Engagement Type	Partner Name
2011 - ongoing	Consultant	BeckTon Dickenson

Position: University Professorial Research Fellow (E)
Phone: 81616562
Email: simon.barry@adelaide.edu.au
Fax: 81617031
Campus: Womens & Childrens Hospital
Building: WCH - Clarence Rieger Building, floor 2
Org Unit: Medical Sciences

Professor Simon Barry

Appointments

Education

Research Interests

Journals

Conference Papers

Conference Items

Patents

Theses

Current Higher Degree by Research Supervision (University of Adelaide)

Past Higher Degree by Research Supervision (University of Adelaide)

Board Memberships

Committee Memberships

Memberships

Editorial Boards

Industry Partnerships

Connect With Me

External Profiles

Other Links